Changli Wang

442 total citations
18 papers, 302 citations indexed

About

Changli Wang is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Changli Wang has authored 18 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 10 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Changli Wang's work include Cancer-related molecular mechanisms research (12 papers), Circular RNAs in diseases (8 papers) and MicroRNA in disease regulation (8 papers). Changli Wang is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), Circular RNAs in diseases (8 papers) and MicroRNA in disease regulation (8 papers). Changli Wang collaborates with scholars based in China, United States and Australia. Changli Wang's co-authors include Zhenfa Zhang, Yuchen Ma, Nan Sun, Jianqun Ma, Ni Li, Dongsheng Yue, Chenguang Li, Lianmin Zhang, Chen Chen and Hua Zhang and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Energy Materials and International Journal of Molecular Sciences.

In The Last Decade

Changli Wang

14 papers receiving 298 citations

Peers

Countries citing papers authored by Changli Wang

Since Specialization

Citations

This map shows the geographic impact of Changli Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changli Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changli Wang more than expected).

Fields of papers citing papers by Changli Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changli Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changli Wang. The network helps show where Changli Wang may publish in the future.

Co-authorship network of co-authors of Changli Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Changli Wang. A scholar is included among the top collaborators of Changli Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changli Wang. Changli Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Heterointerface-Enabled Anti-Reverse-Current Electrodes for Alkaline Water Electrolyzers at 1000 mA cm ^–2 2025 ·Journal of the American Chemical Society ·Wen-Jun He, Yueshuai Wang, Yilong Zhao, Cheng Tang, Linchuan Cong, Changli Wang, Yue Lu, Xin Liu, Juncai Dong, (unknown), Qingsong Hua, Qiang Zhang	0
2	Li‐Doping and Pyrolysis Engineered Robust Anode for Intermittency‐Resilient AEM Electrolysis 2025 ·Advanced Energy Materials ·Linchuan Cong, Cheng Tang, Xinxin Li, Wen-Jun He, Changli Wang, (unknown), Qiang Zhang	0
3	BAP31 Promotes Epithelial–Mesenchymal Transition Progression Through the Exosomal miR-423-3p/Bim Axis in Colorectal Cancer 2025 ·International Journal of Molecular Sciences ·Changli Wang, (unknown), Sheng Yang, Tianyi Wang, Bing Wang	0
4	Classification of Hyperspectral Images of Explosive Fragments Based on Spatial–Spectral Combination 2024 ·Sensors ·(unknown), Ping Yu, Feng Guo, (unknown), (unknown), Changli Wang, (unknown), (unknown), Bin Zhang	1
5	Double homeobox a pseudogene 8/miR-223-3p/PFN2 modulates radiosensitivity in lung cancer 2023 ·Molecular & Cellular Toxicology ·Chong Pang, Tengyue Zhang, (unknown), Yulong Chen, Chen Chen, Zhenfa Zhang, Changli Wang	0
6	BAP31-Mediated miR-206/133b Cluster Promotes Transendothelial Migration and Metastasis of Colorectal Cancer 2023 ·International Journal of Molecular Sciences ·(unknown), Changli Wang, Yufei Wu, Jingjing Liu, (unknown), Bing Wang	5
7	The mechanism of LncRNA01977 in lung adenocarcinoma through the SDF-1/CXCR4 pathway 2022 ·Translational Cancer Research ·Xiaorong Lai, Changli Wang, (unknown)	6
8	Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients 2022 ·Translational Lung Cancer Research ·Dongsheng Yue, Weiran Liu, Chen Chen, Tao Zhang, Yuchen Ma, Longgang Cui, Yajun Gu, Ting Bei, Xiaochen Zhao, Bei Zhang, Yuezong Bai, Atocha Romero, Meng Xu‐Welliver, Changli Wang, Zhenfa Zhang, Bin Zhang	63
9	Long-chain non-coding RNA LINC00473 antagonist with liposomal nanoparticles as carrier targets for Keap1/Nrf2/ARE signaling pathway to promote lung cancer cell apoptosis 2022 ·Materials Express ·(unknown), Changli Wang, (unknown), (unknown), Haiqin Wu	1
10	miR‐423‐3p activates FAK signaling pathway to drive EMT process and tumor growth in lung adenocarcinoma through targeting CYBRD1 2021 ·Journal of Clinical Laboratory Analysis ·(unknown), (unknown), Chaonan Zhu, Xiaoyan Sun, Qiang Zhang, Lianmin Zhang, Qi Qi, Xiaoming Bai, (unknown), Changli Wang	10
11	Long non‑coding RNA SNHG17 promotes lung adenocarcinoma progression by targeting the microRNA‑193a‑5p/NETO2 axis 2021 ·Oncology Letters ·Zhiwei Zhang, Yulan Yan, Bin Zhang, Yuchen Ma, Chen Chen, Changli Wang	12
12	LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers 2020 ·Cancer Letters ·Chen Chen, (unknown), Bin Zhang, (unknown), Chenguang Li, Chang Liu, Hua Zhang, (unknown), Yuchen Ma, Pengfei Tian, Qi Qi, Jingjing Li, Zhe Tang, Zhenfa Zhang, Giuseppe Giaccone, Dongsheng Yue, Changli Wang	69
13	Persistence of smoking induced non‐small cell lung carcinogenesis by decreasing ERBB pathway‐related microRNA expression 2019 ·Thoracic Cancer ·Lianmin Zhang, Hailong Wang, Changli Wang	14
14	A novel long non‑coding RNATCONS_00001798 is downregulated and predicts survival in patients with non‑small cell lung cancer 2018 ·Oncology Letters ·Liuwei Gao, Hua Zhang, Bin Zhang, Changli Wang	8
15	[Research progress on metabolism of monocytes and macrophages in sepsis]. 2017 ·PubMed ·Changli Wang, Lulong Bo, Xiaoming Deng	5
16	Identification of a three-miRNA signature as a blood-borne diagnostic marker for early diagnosis of lung adenocarcinoma 2016 ·Oncotarget ·Yang Wang, Hua Zhao, Xujie Gao, Feng Wei, Xinwei Zhang, Yanjun Su, Changli Wang, Hui Li, Xiubao Ren	47
17	Positive expression of pro-opiomelanocortin (POMC) is a novel independent poor prognostic marker in surgically resected non-small cell lung cancer 2014 ·Tumor Biology ·(unknown), Xiaoliang Zhao, Bin Zhang, Chenguang Li, Changli Wang	17
18	Expression of Nuclear Factor-κB and Its Clinical Significance in Nonsmall-Cell Lung Cancer 2006 ·The Annals of Thoracic Surgery ·Zhenfa Zhang, Jianqun Ma, Ni Li, Nan Sun, Changli Wang	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact